We are monitoring the impact of COVID-19 on Europe Tumor Ablation Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 430
Share on
Share on

Europe Tumor Ablation Market Research Report – Segmented By Technology, Treatment, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 430
Pages: 139

Europe Tumor Ablation Market Size (2021 to 2026)

The size of the tumor ablation market in Europe was worth USD 0.16 billion in 2021 and is estimated to be growing at a CAGR of 11.6% and worth USD 0.27 billion by 2026.

The demand for tumor ablation is significantly growing in the European region. It is majorly driven by the growing aging population, a significant rise in cancer cases, and government measures to encourage ablation therapy treatment of cancer. In addition, increasing demand for minimally invasive procedures for treating cancer and accelerating awareness of the benefits provided by ablation procedures over traditional surgical procedures are amongst the other factors promoting the market’s growth rate.

Growing investments for research and cancer treatment for new innovative and emerging techniques such as intensity-modulated radiotherapy, photon beam therapy, and clinical trials are expected to favor the European tumor ablation market and provide lucrative growth opportunities globally market for tumor ablation during the forecast period. Besides, the gradually decreasing prices of devices in emerging economies in the region and growing supportive scenario of reimbursement in mature markets are expected to provide renewed growth opportunities to the key market players of the area. Many of the top manufacturers and new market entrants invest heavily in Research & Development activities to create new tumor ablation devices and broaden their current tumor ablation products ' clinical application profile.

However, the lack of medication available, strict regulatory approvals, and high treatment costs are the key factors that impede the growth of the European tumor ablation market. Besides, the ongoing reforms related to healthcare and lack of skilled workers or limited knowledge are other primary factors challenging the tumor ablation market in Europe. On the other hand, ablation treatment-related side effects may impede market growth.

This research report on the European tumor ablation market has been segmented and sub-segmented into the following categories:

By Technology: 

  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Other Ablation Devices

By Treatment: 

  • Surgical Ablation
  • Laparoscopic Ablation
  • Percutaneous Ablation

By Application: 

  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostrate Metastasis
  • Other Cancer

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, due to the increasing prevalence of cancer, Europe is the second-largest market for tumor ablation devices globally. The European market was the second largest regional market globally in 2019. The increasing aging population drove a growing number of cancer cases, where 70% of the cancer cases occurred in people aged between 50 years and above. Increasing awareness of the advantages of ablation procedures over traditional surgical procedures boosts the market growth in this region. The second-largest area in Europe leading the Tumour Ablation market is Germany, followed by France and Italy. It is due to the presence of major key players in these regions investing in the market studied.

In Europe, the UK tumor ablation market accounted for a significant share and is predicted to grow at a promising rate during the forecast period. The UK market is predicted to be fuelled by the growing investments towards research and development and the treatment of cancer for new techniques that boost the increase in the European region. In addition, continuously advanced technologies, increasing awareness in the healthcare industry across the globe, accelerate growth over the analysis period.

Followed by the UK, the German tumor ablation market is estimated to register a healthy growth rate during the forecast period owing to the increasing elder people population, integrated with government support to control cancer and the European Cancer Observatory has targeted to create an awareness regarding cancer, early diagnostic techniques and upgraded minimally invasive therapeutic options. The European nations have invested 16.2% of their total expenditure on healthcare during the analysis period. Moreover, increasing demand for advancements in technologies,

Other countries such as France, Italy, and Sweden are expected to have healthy CAGR in the forthcoming years due to early diagnostic techniques, and advanced minimally invasive surgeries; growing healthcare expenditure, and the growing tendency of surgeons and patients, which owes to advantages like speedy recovery, patient recovery is likely to fuel the growth in the European region.

KEY MARKET PLAYERS:

Medtronic Plc., Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., SonaCare Medical, Misonix, Inc., and Neuwave Medical, Inc. are some of the dominating companies in the European tumor ablation market profiled in this report.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 By Technology                                           

                                5.1.1 Radiofrequency Ablation Devices                 

                                5.1.2 Microwave Ablation Devices                           

                                5.1.3 Cryoablation Devices                          

                                5.1.4 Other Ablation Devices                      

                5.2 By Treatment                                            

                                5.2.1 Surgical Ablation                   

                                5.2.2 Laparoscopic Ablation                        

                                5.2.3 Percutaneous Ablation                      

                5.3 By Application                                           

                                5.3.1 Liver Cancer                            

                                5.3.2 Breast Cancer                        

                                5.3.3 Lung Cancer                            

                                5.3.4 Prostrate Metastasis                          

                                5.3.5 Other Cancers                       

6. Geographical Analysis                                                              

                                6.1 Introduction                               

                                6.2 U.K                 

                                6.3 Spain                             

                                6.4 Germany                     

                                6.5 Italy                               

                                6.6 France                          

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Medtronic Plc.                                           

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Angiodynamics                                         

                8.3 Mermaid Medical                                    

                8.4 HealthTronics                                            

                8.5 Galil Medical Inc.                                      

                8.6 EDAP TMS S.A.                                          

                8.7 Boston Scientific Corporation                                             

                8.8 SonaCare Medical                                    

                8.9 Misonix, Inc.                                              

                8.10 Neuwave Medical, Inc.                                       

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Tumor Ablation Market By Region, From 2021 to 2026 (USD Million)
  2. Europe Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  3. Europe Radiofrequency Ablation Devices Market By Region, From 2021 to 2026 (USD Million)
  4. Europe Microwave Ablation Devices Market By Region, From 2021 to 2026 (USD Million)
  5. Europe Cryoablation Devices Market By Region, From 2021 to 2026 (USD Million)
  6. Europe other Ablation Devices Market By Region, From 2021 to 2026 (USD Million)
  7. Europe Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  8. Europe Surgical Ablation Market By Region, From 2021 to 2026 (USD Million)
  9. Europe Laparoscopic Ablation Market By Region, From 2021 to 2026 (USD Million)
  10. Europe Percutaneous Ablation Market By Region, From 2021 to 2026 (USD Million)
  11. Europe Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)
  12. Europe Liver Cancer Market By Region, From 2021 to 2026 (USD Million)
  13. Europe Breast Cancer Market By Region, From 2021 to 2026 (USD Million)
  14. Europe Lung Cancer Market By Region, From 2021 to 2026 (USD Million)
  15. Europe Prostrate Metastasis Market By Region, From 2021 to 2026 (USD Million)
  16. Europe other cancer Market By Region, From 2021 to 2026 (USD Million)
  17. U.K Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  18. U.K Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  19. U.K Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)
  20. Spain Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  21. Spain Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  22. Spain Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)
  23. Germany Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  24. Germany Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  25. Germany Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)
  26. Italy Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  27. Italy Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  28. Italy Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)
  29. France Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  30. France Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  31. France Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample